Kreiskrankenhaus Gummersbach GmbH
Gummersbach, Germany
General hospital in Gummersbach, North Rhine-Westphalia
Wilhelm - Breckow - Allee 20, 51643 Gummersbach
About Kreiskrankenhaus Gummersbach GmbH
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
German High-Grade Non-Hodgkin's Lymphoma Study Group
2
Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany
2
Janssen Research & Development, LLC
1
Johannes Gutenberg University Mainz
1
MEDA Pharma GmbH & Co. KG
1
Martin-Luther-Universität Halle-Wittenberg
1
Universität des Saarlandes
1
Clinical Trials at Kreiskrankenhaus Gummersbach GmbH
During the past decade, Kreiskrankenhaus Gummersbach GmbH conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma
1997-05-01
2002-02-01
Completed
Observation of Young Patients Who Are Undergoing Surgery for Craniopharyngioma
2001-05-01
2009-09-01
Completed
120
Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma
2005-11-01
2018-08-01
Completed
592
Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma
2004-02-01
2015-11-01
Completed
586
Effectiveness of Adjuvant Radiotherapy in Small Oropharyngeal Squamous Cell Cancer and Single Lymph Node Metastasis.
2009-10-01
2021-12-01
Completed
209
Efficacy of FOLFOX+Bevacizumab in Combination With Irinotecan in the Treatment of Metastatic Colorectal Cancer
2011-05-01
2018-08-15
Completed
250
OPTIMAL>60 / DR. CHOP, Improvement of Therapy of Elderly Patients With CD20+ DLBCL Using Rituximab Optimized and Liposomal Vincristine
2011-11-01
2024-05-01
Active, not recruiting
1,152
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kreiskrankenhaus Gummersbach GmbH" #1 sponsor was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 2 trials, followed by "Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany" with 2 trials
sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored, "Johannes Gutenberg University Mainz" with 1 trials sponsored and "MEDA Pharma GmbH & Co. KG"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kreiskrankenhaus Gummersbach GmbH"
#1 collaborator was "Clinipace Worldwide" with 1 trials as a collaborator, "Deutsche Krebshilfe e.V., Bonn (Germany)" with 1 trials as a collaborator, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 1 trials as a collaborator, "ICON plc" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at Kreiskrankenhaus Gummersbach GmbH
According to Clinical.Site data, the most researched conditions in "Kreiskrankenhaus Gummersbach GmbH" are
"Lymphoma" (2 trials), "Brain and Central Nervous System Tumors" (1 trials), "CD20+ Aggressive B-Cell Lymphoma" (1 trials), "Long-term Effects Secondary to Cancer Therapy in Children" (1 trials) and "Lymph Node Metastasis" (1 trials). Many other conditions were trialed in "Kreiskrankenhaus Gummersbach GmbH" in a lesser frequency.
Clinical Trials Intervention Types at Kreiskrankenhaus Gummersbach GmbH
Most popular intervention types in "Kreiskrankenhaus Gummersbach GmbH" are "Drug" (7 trials), "Radiation" (4 trials), "Biological" (3 trials), "Other" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "cyclophosphamide" (3 trials), "doxorubicin hydrochloride" (3 trials), "radiation therapy" (3 trials), "vincristine sulfate" (3 trials) and "conventional surgery" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Kreiskrankenhaus Gummersbach GmbH
The vast majority of trials in "Kreiskrankenhaus Gummersbach GmbH" are
9 trials for "All" genders.
Clinical Trials Status at Kreiskrankenhaus Gummersbach GmbH
Currently, there are NaN active trials in "Kreiskrankenhaus Gummersbach GmbH".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Kreiskrankenhaus Gummersbach GmbH,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Kreiskrankenhaus Gummersbach GmbH, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".